BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 24471413)

  • 1. Severity of lower urinary tract symptoms reflects different composition of bladder storage dysfunction and bladder outlet obstruction in men with symptomatic benign prostatic hyperplasia.
    Jhang JF; Liao CH; Kuo HC
    Int J Clin Pract; 2014 Jun; 68(6):743-8. PubMed ID: 24471413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construct validation of patient global impression of severity (PGI-S) and improvement (PGI-I) questionnaires in the treatment of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Viktrup L; Hayes RP; Wang P; Shen W
    BMC Urol; 2012 Nov; 12():30. PubMed ID: 23134716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Effects of Oral Supplementation of Gamma-Cyclodextrin Curcumin Complex in Male Patients with Moderate-To-Severe Benign Prostatic Hyperplasia-Related Lower Urinary Tract Symptoms.
    Crocerossa F; Cantiello F; Bagalá L; Sicoli F; Carbonara U; Manfredi C; Falagario U; Veccia A; Pandolfo SD; Napolitano L; Ferro M; Di Dio M; Mondaini N; Damiano R
    Urol Int; 2023; 107(10-12):924-934. PubMed ID: 37939691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the effect of Alfuprost MR on detrusor thickness and bladder mass in patients with detrusor hypertrophy caused by benign prostatic hyperplasia].
    Kuzmenko A V; Kuzmenko V V; Gyaurgiev T A
    Urologiia; 2023 Dec; (6):14-21. PubMed ID: 38156678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of oral drug therapies for lower urinary tract symptoms due to benign prostatic hyperplasia: a systematic review and network meta-analysis.
    Wang X; Wang X; Li S; Meng Z; Liu T; Zhang X
    PLoS One; 2014; 9(9):e107593. PubMed ID: 25216271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of CYP2D6 allelic variants on therapy with tamsulosin in patients with benign prostatic hyperplasia.
    Abdullaev SP; Shatokhin MN; Tuchkova SN; Abdullaev SP; Teodorovich OV; Loran OB; Sychev DA
    Drug Metab Pers Ther; 2023 Dec; 38(4):323-330. PubMed ID: 37656138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients presenting with lower urinary tract symptoms who most deserve to be investigated for primary bladder neck obstruction.
    Schifano N; Capogrosso P; Matloob R; Boeri L; Candela L; Fallara G; Costa A; Pozzi E; Belladelli F; Cazzaniga W; Abbate C; Montorsi F; Salonia A
    Sci Rep; 2021 Feb; 11(1):4167. PubMed ID: 33603071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of postoperative storage symptoms in male patients with lower urinary tract symptoms: A retrospective analysis of prostate surgery for benign prostatic enlargement.
    Ito H; Takanashi M; Fukazawa T; Takizawa H; Hioki M; Shinoki R; Kawahara T; Makiyama K; Kobayashi K
    Low Urin Tract Symptoms; 2024 May; 16(3):e12512. PubMed ID: 38602061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Distribution of Postvoid Residual Urine Volume in a Hospital-Based Sample of Men with Symptomatic Benign Prostatic Hyperplasia.
    Anyimba SK; Amu OC; Nnabugwu II; Okoh AD; Nwachukwu CD; Iwenofu CA
    Niger J Clin Pract; 2023 Dec; 26(12):1839-1843. PubMed ID: 38158350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Persistent Lower Urinary Tract Symptoms 1 Month Following Convective Water Vapor Thermal Therapy (CWVTT-Rezum).
    Janakiraman S; Felice M; Pahouja G; Adams W; Bsatee A; Farooq A; McVary KT
    Urology; 2023 Sep; 179():112-117. PubMed ID: 37353091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of detrusor wall thickness (DWT) with lower urinary tract symptom severity in benign prostatic hyperplasia: a cross-sectional study.
    Bhattarai K; Khadka H; Thapa BR; Katwal S
    Ann Med Surg (Lond); 2024 Jun; 86(6):3249-3254. PubMed ID: 38846812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically Meaningful Improvements in LUTS/BPH Severity in Men Treated with Silodosin Plus Hexanic Extract of Serenoa Repens or Silodosin Alone.
    Boeri L; Capogrosso P; Ventimiglia E; Cazzaniga W; Pederzoli F; Moretti D; Dehò F; Montanari E; Montorsi F; Salonia A
    Sci Rep; 2017 Nov; 7(1):15179. PubMed ID: 29123161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of electroacupuncture and its cotreatment with electronic moxibustion in the treatment of patients with moderate benign prostatic hyperplasia using alpha blocker: An assessor-blinded, randomized, controlled pilot study.
    Kim HB; Han CH; Jeon JH; Kim E; Kwon O; Choi YE; Yang C; Park YC; Kim YI
    Medicine (Baltimore); 2022 Sep; 101(36):e30386. PubMed ID: 36086755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder Outlet Obstruction Relief and Symptom Improvement Following Medical and Surgical Therapies for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Systematic Review.
    Creta M; Russo GI; Bhojani N; Drake MJ; Gratzke C; Peyronnet B; Roehrborn C; Tikkinen KAO; Cornu JN; Fusco F
    Eur Urol; 2024 May; ():. PubMed ID: 38749852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Practical use of Adenoprosin in combination therapy in men with lower urinary tract symptoms].
    Kasyan G R; Khodyreva L A; Grigoryan B L; Dyakov V V
    Urologiia; 2024 Mar; (1):61-70. PubMed ID: 38650408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships among participant international prostate symptom score, benign prostatic hyperplasia impact index changes and global ratings of change in a trial of phytotherapy in men with lower urinary tract symptoms.
    Barry MJ; Cantor A; Roehrborn CG;
    J Urol; 2013 Mar; 189(3):987-92. PubMed ID: 23017510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of traditional outcome measures and self-assessed goal achievement in patients treated surgically for benign prostatic hyperplasia.
    Pratsinis M; Müllhaupt G; Güsewell S; Betschart P; Zumstein V; Engeler D; Schmid HP; Lamb AD; Abt D
    World J Urol; 2023 Apr; 41(4):1125-1131. PubMed ID: 36795145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of L-Carnitine and Coenzyme Q10 Supplementation on Lower Urinary Tract Symptoms in Men with Benign Prostatic Hyperplasia: A Randomized, Controlled, Clinical Trial.
    Norouzi M; Mahboobi S; Eftekhari MH; Salehipour M; Ghaem H; Mirzakhanlouei A; Mohsenpour MA
    Nutr Cancer; 2024; 76(2):207-214. PubMed ID: 38105612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Seoritae Extract in Men with Mild to Moderate Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia.
    Bae WJ; Park HJ; Koo HC; Kim do R; Ha US; Kim KS; Kim SJ; Cho HJ; Hong SH; Lee JY; Hwang SY; Kim SW
    Evid Based Complement Alternat Med; 2016; 2016():1960926. PubMed ID: 27382404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of tamsulosin 0.4 mg as an initial dose in 1,219 Korean patients with moderate to severe lower urinary tract symptoms: data from a phase IV study.
    Lee JH; Park YW; Park MH; Yoo TK
    Prostate Int; 2023 Dec; 11(4):228-232. PubMed ID: 38196556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.